Detalhe da pesquisa
1.
Recurrent chromosomal translocations in sarcomas create a megacomplex that mislocalizes NuA4/TIP60 to Polycomb target loci.
Genes Dev
; 36(11-12): 664-683, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35710139
2.
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.
Am J Hum Genet
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723632
3.
Generation of an Inhibitory NK Cell Subset by TGF-ß1/IL-15 Polarization.
J Immunol
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38668728
4.
Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma.
J Proteome Res
; 23(2): 749-759, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266179
5.
Primary cytoreductive surgery compared with neoadjuvant chemotherapy in patients with BRCA mutated advanced high grade serous ovarian cancer: 10 year survival analysis.
Int J Gynecol Cancer
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548312
6.
Sustainability of an enhanced recovery pathway after minimally invasive gynecologic oncology surgery.
Int J Gynecol Cancer
; 34(5): 738-744, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531541
7.
Computational modeling of ovarian cancer dynamics suggests optimal strategies for therapy and screening.
Proc Natl Acad Sci U S A
; 118(25)2021 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161278
8.
Identification of antigenic epitopes recognized by tumor infiltrating lymphocytes in high grade serous ovarian cancer by multi-omics profiling of the auto-antigen repertoire.
Cancer Immunol Immunother
; 72(7): 2375-2392, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36943460
9.
Using a machine learning algorithm to predict outcome of primary cytoreductive surgery in advanced ovarian cancer.
J Surg Oncol
; 127(3): 465-472, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350138
10.
Mucin 13 (MUC13) as a candidate biomarker for ovarian cancer detection: potential to complement CA125 in detecting non-serous subtypes.
Clin Chem Lab Med
; 61(3): 464-472, 2023 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36380677
11.
Validation of the Integrated Prediction Model algorithm for outcome of cytoreduction in advanced ovarian cancer.
Int J Gynecol Cancer
; 33(7): 1077-1082, 2023 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015756
12.
Validation of the KELIM score as a predictor of response to neoadjuvant treatment in patients with advanced high grade serous ovarian cancer.
Gynecol Oncol
; 167(3): 417-422, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191644
13.
Integrated prediction model of patient factors, resectability scores and surgical complexity to predict cytoreductive outcome and guide treatment plan in advanced ovarian cancer.
Gynecol Oncol
; 166(3): 453-459, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35820987
14.
Treatment outcomes and predictive factors in patients ≥70 years old with advanced ovarian cancer.
J Surg Oncol
; 125(4): 736-746, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34786711
15.
A prospective comparison of costs between robotics, laparoscopy, and laparotomy in endometrial cancer among women with Class III obesity or higher.
J Surg Oncol
; 125(4): 747-753, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34904716
16.
The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma.
Int J Gynecol Cancer
; 32(4): 525-531, 2022 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969829
17.
Oncologic and pregnancy outcomes after fertility-sparing surgery for stage I, low-grade endometrioid ovarian cancer.
Int J Gynecol Cancer
; 2022 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35768155
18.
Enhanced recovery after minimally invasive gynecologic oncology surgery to improve same day discharge: a quality improvement project.
Int J Gynecol Cancer
; 32(4): 457-465, 2022 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34987097
19.
Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.
Int J Gynecol Cancer
; 32(7): 891-898, 2022 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35012974
20.
Maximizing cancer prevention through genetic navigation for Lynch syndrome detection in women with newly diagnosed endometrial and nonserous/nonmucinous epithelial ovarian cancer.
Cancer
; 127(17): 3082-3091, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33983630